ZNTL
Zentalis Pharmaceuticals, Inc.
NASDAQ · Healthcare · Biotechnology · US
$3.99
−2.92%1
Insider buys (3m)
0
Insider sells (3m)
$15.2M
Net value (3m)
+8.2%
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| Aug 19, 2026 | WALTERS GROUP · 10 percent owner | Purchase | 4,335,000 | $3.50 |
| Jun 18, 2026 | Johnson David Michael · director | A-Award | 57,100 | $0.00 |
| Jun 18, 2026 | Skvarka Jan · director | A-Award | 57,100 | $0.00 |
| Jun 18, 2026 | Kariuki Enoch · director | A-Award | 57,100 | $0.00 |
| Jun 18, 2026 | Walker Luke Nathaniel · director | A-Award | 57,100 | $0.00 |
| Jun 18, 2026 | Myers Scott Dunseth · director | A-Award | 57,100 | $0.00 |
| May 27, 2026 | Campbell Shannon · director | A-Award | 114,200 | $0.00 |
| Feb 10, 2026 | Bruns Ingmar · officer: Chief Medical Officer | Sale | 2,962 | $2.43 |
| Feb 10, 2026 | Vultaggio Vincent · officer: PAO and PFO | Sale | 3,379 | $2.39 |
| Feb 10, 2026 | Bruns Ingmar · officer: Chief Medical Officer | Sale | 335 | $2.39 |
| Feb 10, 2026 | EASTLAND JULIA MARIE · director, officer: CEO & President | Sale | 7,866 | $2.43 |
| Feb 10, 2026 | Vultaggio Vincent · officer: PAO and PFO | Sale | 6,894 | $2.42 |
| Feb 10, 2026 | EASTLAND JULIA MARIE · director, officer: CEO & President | Sale | 889 | $2.39 |
| Feb 10, 2026 | Vultaggio Vincent · officer: PAO and PFO | Sale | 29,951 | $2.43 |
| Feb 4, 2026 | Vultaggio Vincent · officer: PAO and PFO | Sale | 2,540 | $2.55 |
| Feb 4, 2026 | Vultaggio Vincent · officer: PAO and PFO | Sale | 556 | $2.52 |
| Jan 9, 2026 | Bruns Ingmar · officer: Chief Medical Officer | A-Award | 365,000 | $2.84 |
| Jan 9, 2026 | Vultaggio Vincent · officer: PAO and PFO | A-Award | 100,000 | $2.84 |
| Jan 9, 2026 | EASTLAND JULIA MARIE · director, officer: CEO & President | A-Award | 775,000 | $2.84 |
| Jan 9, 2026 | Bucher James B · officer: Chief Legal Officer | A-Award | 100,000 | $2.84 |
| Jan 8, 2026 | WALTERS GROUP · 10 percent owner | Purchase | 6,459,973 | $1.20 |
| Dec 15, 2025 | Matrix Capital Management Company, LP · 10 percent owner | Sale | 7,500,000 | $1.33 |
| Oct 1, 2025 | Bucher James B · officer: Chief Legal Officer | A-Award | 400,000 | $1.54 |
| Jun 18, 2025 | Kariuki Enoch · director | A-Award | 57,603 | $0.00 |
| Jun 18, 2025 | Skvarka Jan · director | A-Award | 57,603 | $0.00 |
| Jun 18, 2025 | Myers Scott Dunseth · director | A-Award | 57,603 | $0.00 |
| Jun 18, 2025 | Walker Luke Nathaniel · director | A-Award | 57,603 | $0.00 |
| Jun 18, 2025 | Johnson David Michael · director | A-Award | 57,603 | $0.00 |
| Apr 30, 2025 | Myers Scott Dunseth · director | Purchase | 21,000 | $1.40 |
| Feb 12, 2025 | Bruns Ingmar · officer: Chief Medical Officer | Purchase | 20,000 | $2.28 |
Institutional positioning
13F filings over the trailing two quarters
New 27Increased 29Reduced 31Sold out 98
| Filer | Action | Shares | Filed |
|---|---|---|---|
| Squadron Capital Management LLC | New Position | 4,031,000 | May 15, 2026 |
| 5AM VENTURE MANAGEMENT, LLC | Unchanged | 3,947,913 | May 15, 2026 |
| TWO SIGMA INVESTMENTS, LP | Increased | 2,956,526 | May 15, 2026 |
| ACADIAN ASSET MANAGEMENT LLC | Reduced | 2,848,252 | May 13, 2026 |
| CITADEL ADVISORS LLC | Increased | 2,337,803 | Sep 2, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | New Position | 2,310,707 | May 15, 2026 |
| RENAISSANCE TECHNOLOGIES LLC | Reduced | 1,938,145 | May 14, 2026 |
| CITADEL ADVISORS LLC | Reduced | 1,756,283 | May 15, 2026 |
| D. E. SHAW & CO., INC. | Reduced | 1,484,098 | May 15, 2026 |
| OPALEYE MANAGEMENT INC. | Reduced | 1,412,656 | May 15, 2026 |
| DECHENG CAPITAL LLC | Unchanged | 1,323,327 | May 13, 2026 |
| MILLENNIUM MANAGEMENT LLC | Increased | 1,289,822 | May 15, 2026 |
| BLACKROCK, INC. | Increased | 1,269,837 | May 13, 2026 |
| Ishara Investments LP | Reduced | 1,230,000 | May 15, 2026 |
| BANK OF AMERICA CORP /DE/ | Reduced | 1,132,294 | May 18, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Aug 19, 2026